Citigroup
ASXC

Citigroup’s Asensus Surgical, Inc. ASXC Stock Holding History

Citigroup’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,448
Closed -$4K – 7807
2019
Q4 		$4K Sell
2,448
-67
-3% -$233 ﹤0.01% 7468
2019
Q3 		$20K Buy
2,515
+61
+2% +$829 ﹤0.01% 6746
2019
Q2 		$43K Sell
2,454
-169
-6% -$3.7K ﹤0.01% 6615
2019
Q1 		$81K Sell
2,623
-1,623
-38% -$54.4K ﹤0.01% 5951
2018
Q4 		$125K Sell
4,246
-3,700
-47% -$168K ﹤0.01% 5468
2018
Q3 		$599K Sell
7,946
-6,446
-45% -$436K ﹤0.01% 4069
2018
Q2 		$816K Buy
14,392
+10,754
+296% +$392K ﹤0.01% 3578
2018
Q1 		$81K Sell
3,638
-1,577
-30% -$36.1K ﹤0.01% 5794
2017
Q4 		$131K Buy
5,215
+3,938
+308% +$121K ﹤0.01% 5412
2017
Q3 		$24K Buy
1,277
+839
+192% +$9.76K ﹤0.01% 6386
2017
Q2 		$4K Sell
438
-508
-54% -$4.83K ﹤0.01% 6831
2017
Q1 		$15K Sell
946
-146
-13% -$2.53K ﹤0.01% 6400
2016
Q4 		$18K Buy
1,092
+223
+26% +$4.57K ﹤0.01% 6568
2016
Q3 		$19K Buy
869
+154
+22% +$2.81K ﹤0.01% 6243
2016
Q2 		$11K Sell
715
-993
-58% -$31.2K ﹤0.01% 6510
2016
Q1 		$94K Buy
+1,708
New +$73.2K ﹤0.01% 5706

Other funds holding ASXC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citigroup's ASXC Position: Q2 2023 in Review

Citigroup sold out of Asensus Surgical, Inc. (ASXC) in Q2 2023, closing a stake of 3,047 shares — an estimated $2K sold.

Citigroup first reported a position in ASXC in Q2 2014 and held it in 33 quarters. The position peaked at $523K in Q3 2018. 80 funds tracked by Wall St. Rank hold ASXC as of Q2 2023.

  • Citigroup reported no remaining Asensus Surgical, Inc. position as of Q2 2023 after selling out during the quarter.
  • Citigroup sold 3,047 Asensus Surgical, Inc. shares in Q2 2023, an estimated $2K.
  • Citigroup first reported a position in Asensus Surgical, Inc. in Q2 2014 and held it in 33 quarters.
  • Citigroup's Asensus Surgical, Inc. position peaked at $523K in Q3 2018.
  • 80 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q2 2023.

Based on Citigroup's 13F filing for Q2 2023, filed 10 Aug 2023.